Exagen Inc. (XGN)
NASDAQ · Healthcare
Exagen Inc. Income Statement 2018–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 66.6M | 55.6M | 52.5M | 45.6M | 48.3M | 42.0M | 40.4M | 32.4M |
| Gross Profit | 38.8M | 33.1M | 29.5M | — | — | — | — | — |
| Profitability | ||||||||
| Operating Income | -14.1M | -13.6M | -22.8M | -46.1M | -24.1M | -15.2M | -9.3M | -4.9M |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Income | -20.0M | -15.1M | -23.7M | -47.4M | -26.9M | -16.7M | -12.0M | -8.0M |
| Per Share Data | ||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 22M | 18M | 18M | 17M | 16M | 13M | 13M | 0M |
Exagen Inc. Income Statement — FAQ
Exagen Inc. (XGN) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XGN's income statement history?
The chart and table above show Exagen Inc.'s income statement by year and by quarter, including the growth rate.